PAOG Engages Saul Kaye, Founder of iCAN: Israel-Cannabis and CannaTech to Prepare RespRx for IND

Sandusky, Ohio–(Newsfile Corp. – October 1, 2020) – PAO Group, Inc. (OTC Pink: PAOG) today announced engaging Saul Kaye, the founder of iCAN (www.israel-cannabis.com) and CannaTech (www.canna-tech.co) to provide an independent review of PAOG’s RespRx research for the treatment of Chronic Obstructive Pulmonary Disease (COPD), and to help prepare RespRx for engaging with a contract research organization (CRO) to advance…

Read More